User:Coffeeandcrumbs/Beth Karlan

Best sources missed by Quicksilver

 * Karlan, director of the Women's Cancer Research Institute at Cedars-Sinai Medical Center
 * Karlan, director of the Women's Cancer Program at the Samuel Oschin Cancer Institute at at Cedars-Sinai Medical Center
 * Karlan, who treated [Angelina] Jolie's mother
 * Karlan, who treated [Angelina] Jolie's mother




 * Karlan, who directs the Women's Cancer Research Institute at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute in Los Angeles
 * Karlan will continue to tell her patients who aren't at high risk that they shouldn't be screened
 * Karlan is conducting a study of CA-125 in combination with another marker called HE4.
 * Karlan is conducting a study of CA-125 in combination with another marker called HE4.


 * director of gynecologic oncology at Cedars Sinai Medical Center in Los Angeles
 * who was not involved in the study but presented a commentary on it, said CA125 testing should be done less frequently
 * Beth Karlan AB ’78, MD ’82 | Director, Women’s Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center | Professor of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA
 * Beth Karlan AB ’78, MD ’82 | Director, Women’s Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center | Professor of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA
 * Beth Karlan AB ’78, MD ’82 | Director, Women’s Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center | Professor of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA


 * The President also announced his intent to appoint the following individuals to key Administration posts: Beth Karlan – Member, National Cancer Advisory Board
 * Karlan is the Board of Governors’ Endowed Chair in Gynecologic Oncology at Cedars-Sinai Medical Center, a position she has held since 1995.
 * She has been Associate Director of Women’s Cancer Programs at the Samuel Oschin Comprehensive Cancer Institute since 2010 and Editor-in-Chief of Gynecologic Oncology since 2008.
 * Since 2001, Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California at Los Angeles
 * Director of the Division of Gynecologic Oncology at Cedars-Sinai Medical Center since 1995
 * member, Board of Directors of the Conquer Cancer Foundation
 * 2002, Chair of the Department of Defense Ovarian Cancer Research Program Integration Panel
 * 2005, President of the Society of Gynecologic Oncologists
 * Karlan received a B.A. from Harvard College and an M.D. from Harvard Medical School
 * Karlan received a B.A. from Harvard College and an M.D. from Harvard Medical School



Sources provided by Quicksilver

 * Nothing on this website is usual on a BLP.
 * Karlan was a student at Harvard University in the early 1980s, she was doing her rounds and presenting the case of a Jewish woman in her 30s who had ovarian cancer. The woman suddenly sat up and pointed a finger at Karlan and said, “What right do you have to stand there and pursue your dreams to become a doctor and I’m going to sit here and die?” It was one of those seminal moments that helped lead Karlan down the path to a career in OB-GYN oncology.
 * as director of the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, and after decades of research, Karlan has just launched the BRCA Founder Outreach Study (BFOR), which is offering BRCA genetic testing at no cost to 4,000 eligible men and women, ages 25 and older, of Ashkenazi (Eastern European) Jewish ancestry.
 * Karlan progressed in her career, she began to recognize family clusterings in OB-GYN oncology. “I would see these clusterings of sisters whose moms had died,” she said.
 * Karlan also treated Gilda Radner, who died of ovarian cancer in 1989, and she launched the Gilda Radner Hereditary Cancer Program in 1991. The BRCA1 gene would not be discovered until 1994, with the BRCA2 gene being discovered a year late
 * This source was initially dead. I found it here: https://web.archive.org/web/20151028014023/http://www.cancerletter.com/articles/20151023_4
 * Beth Karlan, professor of obstetrics and gynecology; director of the Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute; and director of the division of gynecologic oncology at Cedars-Sinai Medical Center. Karlan also serves as the director of the Gilda Radner Ovarian Detection Program at Cedars-Sinai Medical Center.
 * Useless. Says nothing substantive about Karlan.
 * This source was initially dead. I found it here: https://web.archive.org/web/20151028014023/http://www.cancerletter.com/articles/20151023_4
 * Beth Karlan, professor of obstetrics and gynecology; director of the Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute; and director of the division of gynecologic oncology at Cedars-Sinai Medical Center. Karlan also serves as the director of the Gilda Radner Ovarian Detection Program at Cedars-Sinai Medical Center.
 * Useless. Says nothing substantive about Karlan.
 * Useless. Says nothing substantive about Karlan.